Parents on alert as Roblox CEO says online dating is planned for the site popular with children
Mr Baszucki said that online dating on the platform was logical given some people's shyness or fear of the dating scene. Roblox users, he said, would 'have a virtual date to start and then, if they connect, move to the physical world.'
In this way, he told the American podcast Tech Stuff, Roblox could become a 'wellness platform,' and something to 'help loneliness and bring connection.'
However, Mr Baszucki said Roblox would seek to make the feature restricted to those over 21.
Roblox's future plans come as Ireland, the UK and Australia attempt to impose stricter age verification conditions online for social media and adult content.
The latest phase of Ireland's Online Safety Code came into effect last week, with online platforms told that enforcement of a requirement for 'effective' age verification measures to stop underage users accessing inappropriate content was now active.
The move has led to only partial compliance by social media firms, with some adult content restricted for newly-set up accounts. However, a survey by the Irish Independent shows that Facebook, Instagram, TikTok, YouTube and X still require only self-declared age to create adult accounts and access some adult content.
Within minutes, the test child user's account was being served hardcore pornography on X
Posing as a child user, the Irish Independent created new adult accounts for all the main social media services, as well as for adult-only services Pornhub and OnlyFans.
Within minutes, the test child user's account was being served hardcore pornography on X, as well as adult-themed content on Instagram.
According to a CyberSafeKids survey of 5,000 primary school children, 75pc of Irish children between eight and 12 have a YouTube account, while 74pc of children between 12 and 14 have a TikTok account, 84pc are on SnapChat and over half have an Instagram account, despite the minimum age requirement being 13.
The media regulator is directly responsible for enforcement on companies headquartered in Ireland, which include Meta (Facebook, Instagram), TikTok, Google (YouTube) and X.
Roblox uses Amsterdam as its EU headquarters, as does Reddit. Snapchat and OnlyFans use the UK as their EU offices, while Pornhub uses Luxembourg.
For services outside Ireland, the Irish regulator must liaise with European authorities in the countries where those services are based.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
2 hours ago
- Irish Examiner
Trump's global tariff agenda puts Ireland's pharmaceutical industry at serious risk
The whole world is in thrall to the whims of Donald Trump's tariff agenda, as it has been since the 47th president of the United States' swearing-in last January. We've learned a few uncomfortable truths along the way. Much of the early outcry from America's allies and trading partners surrounded the lack of economic logic to the imposition of tariffs – which are effectively a tax for Americans on foreign products, in theory making them less attractive to US consumers and heightening the allure of their own domestic suppliers. Critics said that the new regime would disrupt the world economy needlessly and perhaps bring about a global recession. That may well come to pass. The problem is that in this stand-off America has the greater wherewithal in terms of raw economic power. It holds the cards as Trump himself might say. And nations worldwide are beginning to fall into line, the EU just the latest after agreeing to a blanket 15% tariff on goods and services going forward. After President of the European Commission Ursula von der Leyen and US President Donald Trump agreed the trade deal, the spin is that the pain of those tariffs is worth it in order to avoid a global trade war. Also, 15% is better than 30% or worse, is the thinking. Photo:The spin is that the pain of those tariffs is worth it in order to avoid a global trade war. Also, 15% is better than 30% or worse, is the thinking. Whether that represents capitulation in the face of bullyboy tactics, given that little or nothing has been asked of the US in return, is a separate conversation. Ireland's pharmaceutical industry Here in Ireland we have a bigger problem though, and that problem is the pharmaceutical industry. That industry contributes massively to the economy here via billions of euro in corporation tax contributions, with about 90 companies employing 50,000 people in highly-paid roles. A total 30,000 of those jobs are with American firms. Should foreign pharmaceutical concerns exit Ireland the impact on the country would be catastrophic. The industry globally had pleaded with Trump for it to be exempted from any tariff regime, ostensibly for altruistic reasons – that lifesaving medicines shouldn't be subject to capricious taxation. At an EU level, the industry asked that the bloc not apply reciprocal tariffs, one wish that has at least been granted. Pfizer is one of the massive American pharmaceutical companies holding bases in Ireland, in this case Cork. File picture: Dan Linehan Oddly enough, in Trump's world of permanent grievance where everyone has been making a sucker of the United States for decades, the outsize presence the US pharmaceutical industry holds in Ireland is one situation on which he indisputably has a legitimate point. Drug prices in the US can retail for as much as five times what an EU citizen would pay. Meanwhile, American pharma firms make a pretty penny avoiding American tax by basing themselves here. Trump's protectionist agenda demands that those jobs and companies should return home. The Government has been worrying about and planning for a worst-case scenario in terms of tariffs on pharmaceuticals for months. Reaction from the pharma companies But what of the pharma industry itself? The official line from the Irish Pharmaceutical Healthcare Association (IPHA), the industry's lobby group here, is that it is reviewing the announcements coming out of Washington as and when they happen 'as key implications for the pharmaceutical sector remain uncertain'. A stance it's hard to argue with given the whole world has grown used to the haphazard nature of the Trump administration's demands. The European Federation of Pharmaceutical Industries and Associations (EFPIA) notes that tariffs are 'a blunt instrument that will disrupt supply chains, impact on investment in research and development, and ultimately harm patient access to medicines on both sides of the Atlantic'. It added that if the goal is to rebalance trade and ensure a 'fairer distribution' of how pharmaceutical innovation is financed, then 'there are more effective means than tariffs that would help'. Impact on pharma in Ireland The IDA, the body with prime responsibility for attracting foreign investment to Irish shores, says of the pharma implications that it 'welcomes' the deal made between Europe and the US, arguing it provides 'much-needed certainty for Irish, European and American businesses who together represent the most integrated trading relationship in the world'. 'We are very much reliant (on the US market), there's no arguing with that,' says one industry insider. Last year a massive €44bn in pharmaceutical products were exported directly from Ireland to the US. 'But when you stand back €100bn was exported globally. So half went to America, but it's not like all business went there, though it is certainly the biggest partner,' says the source. That doesn't mean that those massive American companies holding bases here – MSD, Pfizer, ELI Lilly, Johnson and Johnson etc – are about to up sticks on the back of the new tariff regime. 'They are not going to leave today or tomorrow, no. But it could definitely impact future investment decisions,' the source says. One of the problems is that a great deal of uncertainty still surrounds the 15% tariff agreement, particularly with regard to pharma. One of the Eli Lilly production buildings at its state-of-the-art facility in Dunderrow, Kinsale, Co Cork. For starters, most people concerned thought that the pharmaceutical industry wasn't to be included in the deal. Then about two hours after the deal was agreed European Commission president Ursula von der Leyen said it would be included, a point Trump appeared to back up. The following day the White House produced a 'fact sheet' describing how the new regime would work, and affirming the 15% rate for pharma. Except that the same sheet stated that the European Union would pay the tariff – which isn't how tariffs work. Then there is the Section 232 investigation which the US Department of Commerce initiated into the pharma industry in April – aiming to establish if how the pharmaceutical system worldwide currently functions impacts negatively on the US from a national security standpoint. Should the answer arrived at be a 'yes', then additional tariffs on pharma may well follow (such investigations typically take a minimum of six months to conclude, so we'll probably get an answer sometime towards the end of the year). 'Pharma plans in the long-term,' says Aidan Meagher, tax partner specialising in life sciences with consultants EY, noting that most pharma manufacturers will have been planning for this scenario for months and will have frontloaded stock into the American market, thus negating immediate impacts in the near term. He says that companies will be likely looking at 'dual sourcing' initiatives, supplying the American market from within the US itself and using Irish operations for its trade around the rest of the globe. 'Ireland needs to up its game' But Meagher says that it would be 'remiss' of Ireland, and the pharma industry here, to take a 'wait and see' approach, perhaps with the supposition that Trump's policies will last for the remaining three-and-a-half years of his term, and no longer. 'It is all about the next investment. A lot of these drugs only have patent protection for a certain life or longevity. Ireland needs to maintain investment and to incentivise the right kind of activity in terms of attracting that innovation,' he says. That means thinking outside the box in terms of tax credits for research and development, and improvements to infrastructure, particularly housing, Meagher says, areas in which we are notably lagging behind in terms of international competition. But he argues that the situation is far from a doomsday scenario. 'It's not as simple as that, it's a whole range of business factors that need to be considered – it's all about impacts for specific companies,' he says. 'It's not all necessarily doom and gloom. Companies have had plenty of time to consider this. And pharma companies are long-term thinkers. Ireland has had just two issues with the FDA (the US food and drug administration, responsible for approving new drugs) in its history. "The country has a strong reputation. These countries have invested significantly and Ireland is the owner of a lot of valuable intellectual property.' But it's certainly not a time to be complacent, Meagher argues. 'We have dropped down the competitiveness radar, and our competitors now aren't in the EU – they're in Switzerland, Singapore and the US itself. We need to be a top competitor for inward investment, and R&D and infrastructure will be critical. That is where Ireland needs to up its game.'
The Journal
4 hours ago
- The Journal
US taxi app Lyft completes acquisition of Freenow for around €175m
US RIDE-HAILING GIANT Lyft has completed its acquisition of taxi app Freenow. In April, Lyft announced it had entered a definitive agreement, for around €175 million , to acquire Freenow from its current owners, German carmakers BMW and Mercedes-Benz. In a statement yesterday, Lyft announced that the acquisition has been completed. Lyft is a North American ride hailing app, that offers rideshare, bikes and scooters – it's second only to Uber in the US market for allowing users book trips with its drivers. Lyft had 23.7 million active riders in 2024. Advertisement In a statement, Lyft said the move will see the two companies 'join forces to seize the incredible opportunity of doubling Lyft's current addressable market to more than 300 billion personal vehicle trips per year'. Lyft CEO David Risher said the move will 'bring out the best of each company to the other' while Freenow CEO Thomas Zimmerman said that for European users of the app, the service will be 'amplified'. 'With Lyft's platform and resources behind us, we can innovate faster and serve drivers, passengers, and city partners even better,' Zimmerman added. For users of the Freenow app, they will be prompted to download Lyft whenever they use Freenow in the US and Canada. Lyft also said that in the coming months, European users will 'experience more consistent pricing and faster matchings'. Meanwhile, Freenow drivers are told to expect more rides as Lyft users will be prompted to download Freenow whenever they are in Europe. Lyft also noted that around 50% of taxi bookings in Europe take place offline and that it is 'committed to strengthen Freenow's leadership in the taxi industry, backed by decades of trusted partnerships with regulators, cities, unions, and fleet operators'. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
The 42
4 hours ago
- The 42
Thurles racecourse announces closure with immediate effect
THURLES RACECOURSE HAS closed with immediate effect and fixtures which had been scheduled for later in the year will not go ahead. The first ever recorded race-meeting at Thurles took place in 1732 and it has been in the hands of the Molony family since the early 1900s. Riona Molony announced the closure in a statement this morning. She thanked the 'extended racecourse family', such as staff, sponsors, the racing community, local businesses, and racegoers for their support. 'It has been an honour and a privilege for our family to have run Thurles Racecourse, and I am officially announcing our retirement today,' said Riona Molony. She said she is 'very proud of the immense contribution our family has made to racing' and remarked that 'horse-racing is part of the fabric of our family'. Advertisement 'My family and I look forward to going racing with you again, as spectators,' she added. The parade ring at Thurles Racecourse Alamy Stock Photo Alamy Stock Photo Her late husband Pierce Molony, who died in 2015, took over the running of the Co Tipperary racecourse from his father Dr Paddy Molony in 1974. 'Since my beloved husband Pierce passed away, with the help of our four daughters Patricia, Helen, Ann Marie and Kate and our wonderful staff, we've managed to keep the show on the road and I know he would be very proud of us for that,' said Riona. She added: 'The girls all have their own families, careers and lives to live. 'Ever increasing industry demands and the cost of doing business has also been a major factor.' Thurles Racecourse is fully licenced to race until 31 December and has 11 prominent fixtures scheduled for the 2025/26 racing calendar. However, these meetings will not go ahead. Riona added: 'We're going to enjoy this time together and relax now the decision is made and the news is out before we consider our options.' 'Surprise to everyone in the industry' The CEO of Horse Racing Ireland, Suzanne Eade, described Thurles Racecourse as a 'cornerstone of the National Hunt programme in Ireland during the winter months'. She said today's announcement 'was a surprise to everyone in the industry'. However, she added that the announcement must have been a 'hugely difficult one' and that she 'respects their decision to take a step back from running racing at Thurles'. Eade remarked that Pierce Molony 'contributed significantly to the Irish racing industry for many years and the Molony family, led by Riona, certainly stepped up following his untimely passing' The Horse Racing Ireland CEO added that she will be seeking a meeting with the Molony family in the near future to discuss their position.
